Navigation Links
Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Date:8/19/2007

Operating Loss Continues to Decline; Strategic Business Unit Realignment Completed; Clinical Update Provided for NicVAX Phase 2b Proof of Concept

Trial

BOCA RATON, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals (Nasdaq: NABI) today announced its second quarter financial results. The company recorded a net loss from continuing operations of $5.3 million, or $0.09 per share, for the quarter ended June 30, 2007, compared to $13.7 million, or $0.22 per share for the quarter ended July 1, 2006. Revenues for the second quarter of 2007 were $20.9 million compared to $20.4 million in 2006. Nabi-HB(R) [Hepatitis B Immune Globulin (Human)] revenues were $8.7 million during the second quarter of 2007 compared to $7.2 million during the second quarter of 2006.

For the six months ended June 30, 2007, the company's net loss from continuing operations was $16.0 million, or $0.26 per share, compared to $29.1 million, or $0.48 per share, for the six months ended July 1, 2006. Revenues for the year to date period were $44.6 million compared to $39.9 million in the first half of 2006.

Total cash used in operating activities was $18.9 million during the first half of 2007, a 44% reduction compared to $33.7 million in the first half of 2006. Excluding discontinued operations, cash used in operating activities was $13.1 million for the first half of 2007, a 53% reduction compared to $27.7 million for six months ended July 1, 2006. Cash, cash equivalents and marketable securities were $103.9 million at the end of the second quarter.

Nabi has completed the formation of two strategic business units (SBUs) -- Nabi Biologics and Nabi Pharmaceuticals -- to realign and
'/>"/>

SOURCE Nabi Biopharmaceuticals

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
3. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Sygnis Pharma AG announces date for presentation of clinical results
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ... Robin , is scheduled to present at the upcoming ... at the Sheraton New York Hotel on Tuesday, ... The presentation will be accessible via a Webcast through a ... the Nektar website: http://www.nektar.com . This Webcast will be ...
(Date:5/16/2013)... Mass. and SYDNEY , May ... - ASX: HIN), a leading innovator of less invasive, ... advanced heart failure, today announced that CEO Doug ... UBS Global Healthcare Conference at 11:00 a.m. EDT on Monday, ... 2013 at the Sheraton New York Hotel. A ...
(Date:5/16/2013)... 16, 2013  Amgen (NASDAQ: AMGN ) will ... May 21, 2013, at the Sheraton New York Times Square ... 10:00 a.m. Eastern Daylight Time. Joseph P. Miletich ... Development at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
Breaking Medicine Technology:Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
(Date:5/18/2013)... Orlando, FL (May 18, 2013) The use ... for a colonoscopy, according to new research presented ... process, which begins days in advance of the ... preparation medication to be taken at strict intervals. ... for doctors to see cancer and precancerous polyps ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) A ground-breaking ... colorectal care, according to research presented today at ... optimizing the minimal withdrawal time for colonoscopies and ... , During colonoscopy, doctors use a device called ... test for colorectal cancer allows a doctor to ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The “World ... analyzes and studies the major market drivers, restraints, and ... the world. , Browse , ... and in-depth TOC on "Healthcare IT Market" ... 10% customization on reports. , The global healthcare IT ...
(Date:5/18/2013)... Wright, KY (PRWEB) May 18, 2013 ... with hearing loss should consider the legal protections they ... claim, when problems arise with their child’s treatment or ... today. , Since 1927, the American Speech-Language-Hearing Association has ... communication disorders and to promote treatment, such as cochlear ...
(Date:5/18/2013)... May 18, 2013 Adolescents, especially young ... as “Spice” or “K2” are landing in emergency rooms ... curb this drug epidemic with a new treatment ... , According to research from the National Institute on ... illegal drug among American teenagers. In 2012, 11 percent ...
Breaking Medicine News(10 mins):Health News:New smartphone application improves colonoscopy preparation 2Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2
... ARBOR, Mich. A review of national data from 1996 through ... or CT, scans to diagnose illnesses in emergency departments, a University ... grew 11 times faster than the rate of ED visits during ... of CT scans was less common early in the study period, ...
... a popular nutritional supplement that is marketed to lead ... the muscle does not increase blood flow as claimed ... nutritional supplements have been developed containing arginine-alpha-ketoglutarate (AAKG), which ... in "vasodilation," the widening of blood vessels and increased ...
... benefit from sessions with trained music therapists or from ... using music can reduce anxiety in cancer patients, and ... quality of life. Music and music therapy ... Treatments range from patients listening to pre-recorded music, to ...
... the University of Leicester demonstrates that psychiatrists are not ... in patients with mental ill health - especially those ... medication, especially those with schizophrenia, have a high rate ... lipid abnormalities, 40% have high blood pressure, and 30% ...
... , TUESDAY, Aug. 9 (HealthDay News) -- Elderly women who ... cognitive impairment or dementia, new research finds. The study ... had 85 percent higher odds of developing mild cognitive impairment ... 15 or more sleep apnea events per hour of sleep. ...
... People with low lifetime levels of physical activity are at ... has found. People with PAD have narrowed leg arteries ... The researchers checked for PAD in 1,381 patients referred ... condition was detected in 258 (19 percent) of these patients. ...
Cached Medicine News:Health News:Use of CT scans in emergency rooms increased 330 percent in 12 years 2Health News:Study finds popular muscle-boosting supplement does not increase blood flow 2Health News:Music reduces anxiety in cancer patients 2Health News:Psychiatrists failing to adequately monitor patients for metabolic side-effects of prescribed drugs 2Health News:Sleep Apnea Could Up Risk of Dementia In Elderly Women 2Health News:Sleep Apnea Could Up Risk of Dementia In Elderly Women 3Health News:Regular Exercise Helps Keep Leg Arteries Clear 2
CPTMeister is a coding reference based on the Physicians' Current Procedural Terminology (CPT) codes developed by the American Medical Association. It is an iSilo document composed of more than 2,000...
The BluefishRx ICD-9 is a Palm OS code lookup tool which incorporates the ICD-9 code set with the full and short code descriptions. It includes a multi keyword search tool with a dictionary of over 2...
MD Coder v 6.0 is a charge capture for the Palm OS and Pocket PC operating systems. We have integrated the feedback from hospitals and physicians. MD Coder v 6.0 comes in three versions: Physician Ba...
Preferred Health Resourses Practice Management System is called Remedy. The PDA version is Remedy for the Palm. It is a data capture program for your medical billing....
Medicine Products: